330 related articles for article (PubMed ID: 10901178)
1. Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats.
Tofovic SP; Kusaka H; Kost CK; Bastacky S
Ren Fail; 2000; 22(4):387-406. PubMed ID: 10901178
[TBL] [Abstract][Full Text] [Related]
2. Caffeine increases renal renin secretion in a rat model of genetic heart failure.
Tofovic SP; Kusaka H; Rominski B; Jackson EK
J Cardiovasc Pharmacol; 1999 Mar; 33(3):440-50. PubMed ID: 10069681
[TBL] [Abstract][Full Text] [Related]
3. Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus.
Velasquez MT; Bhathena SJ; Ranich T; Schwartz AM; Kardon DE; Ali AA; Haudenschild CC; Hansen CT
Kidney Int; 2003 Dec; 64(6):2100-7. PubMed ID: 14633132
[TBL] [Abstract][Full Text] [Related]
4. Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-fa(cp)) rats.
Tofovic SP; Kost CK; Jackson EK; Bastacky SI
Kidney Int; 2002 Apr; 61(4):1433-44. PubMed ID: 11918750
[TBL] [Abstract][Full Text] [Related]
5. Dynamic blood pressure load and nephropathy in the ZSF1 (fa/fa cp) model of type 2 diabetes.
Griffin KA; Abu-Naser M; Abu-Amarah I; Picken M; Williamson GA; Bidani AK
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1605-13. PubMed ID: 17728379
[TBL] [Abstract][Full Text] [Related]
6. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term caffeine consumption on renal function in spontaneously hypertensive heart failure prone rats.
Tofovic SP; Jackson EK
J Cardiovasc Pharmacol; 1999 Mar; 33(3):360-6. PubMed ID: 10069669
[TBL] [Abstract][Full Text] [Related]
8. Appropriateness of the Zucker Diabetic Fatty rat as a model for diabetic microvascular late complications.
Hempe J; Elvert R; Schmidts HL; Kramer W; Herling AW
Lab Anim; 2012 Jan; 46(1):32-9. PubMed ID: 22087029
[TBL] [Abstract][Full Text] [Related]
9. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.
Coimbra TM; Janssen U; Gröne HJ; Ostendorf T; Kunter U; Schmidt H; Brabant G; Floege J
Kidney Int; 2000 Jan; 57(1):167-82. PubMed ID: 10620198
[TBL] [Abstract][Full Text] [Related]
10. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
[TBL] [Abstract][Full Text] [Related]
11. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
[TBL] [Abstract][Full Text] [Related]
12. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes.
Vora JP; Zimsen SM; Houghton DC; Anderson S
J Am Soc Nephrol; 1996 Jan; 7(1):113-7. PubMed ID: 8808117
[TBL] [Abstract][Full Text] [Related]
13. Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats.
Linz D; Hohl M; Mahfoud F; Reil JC; Linz W; Hübschle T; Juretschke HP; Neumann-Häflin C; Rütten H; Böhm M
J Transl Med; 2012 Sep; 10():187. PubMed ID: 22963383
[TBL] [Abstract][Full Text] [Related]
14. Leptin and its relation to obesity and insulin in the SHR/N-corpulent rat, a model of type II diabetes mellitus.
Velasque MT; Bhathena SJ; Hansen CT
Int J Exp Diabetes Res; 2001; 2(3):217-23. PubMed ID: 12369710
[TBL] [Abstract][Full Text] [Related]
15. Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production.
Erdely A; Freshour G; Maddox DA; Olson JL; Samsell L; Baylis C
Diabetologia; 2004 Oct; 47(10):1672-6. PubMed ID: 15490111
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat.
Rodríguez-Iturbe B; Quiroz Y; Shahkarami A; Li Z; Vaziri ND
Kidney Int; 2005 Sep; 68(3):1041-7. PubMed ID: 16105034
[TBL] [Abstract][Full Text] [Related]
17. TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes.
Joshi D; Gupta R; Dubey A; Shiwalkar A; Pathak P; Gupta RC; Chauthaiwale V; Dutt C
J Cardiovasc Pharmacol; 2009 Jul; 54(1):72-81. PubMed ID: 19546815
[TBL] [Abstract][Full Text] [Related]
18. A new animal model of non-insulin-dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats.
Iwase M
Fukuoka Igaku Zasshi; 1991 Jul; 82(7):415-27. PubMed ID: 1833297
[TBL] [Abstract][Full Text] [Related]
19. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
20. Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.
Tofovic DS; Bilan VP; Jackson EK
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):689-91. PubMed ID: 20374254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
